Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
1.760
-0.020 (-1.12%)
Feb 21, 2025, 4:00 PM EST - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $48.41 million as of February 21, 2025. Its market cap has decreased by -32.65% in one year.
Market Cap
48.41M
Enterprise Value
29.81M
1-Year Change
-32.65%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $48.41M, a decrease of -26.36%. That is a compound annual growth rate of -9.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 48.41M | -20.00% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.69B |
| UnitedHealth Group | 463.32B |
| Johnson & Johnson | 383.46B |
| Novo Nordisk | 370.06B |
| AbbVie | 352.34B |
| Abbott Laboratories | 230.31B |
| AstraZeneca | 227.07B |
| Merck & Co. | 219.62B |